Decrease of 3243 A→G mtDNA Mutation from Blood in MELAS Syndrome: A Longitudinal Study
AUTOR(ES)
Rahman, S.
FONTE
The American Society of Human Genetics
RESUMO
It is widely held that changes in the distribution of mutant mtDNAs underlie the progressive nature of mtDNA diseases, but there are few data documenting such changes. We compared the levels of 3243 A→G mutant mtDNA in blood at birth from Guthrie cards and at the time of diagnosis in a blood DNA sample from patients with mitochondrial encephalopathy, lactic acidosis, and strokelike episodes (MELAS) syndrome. Paired blood DNA samples separated by 9–19 years were obtained from six patients with MELAS. Quantification of mutant load, by means of a solid-phase minisequencing technique, demonstrated a decline (range 12%–29%) in the proportion of mutant mtDNA in all cases (P=.0015, paired t-test). These results suggest that mutant mtDNA is slowly selected from rapidly dividing blood cells in MELAS.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1234919Documentos Relacionados
- Comparison of the relative levels of the 3243 (A-->G) mtDNA mutation in heteroplasmic adult and fetal tissues.
- Fine mapping of mitochondrial RNAs derived from the mtDNA region containing a point mutation associated with MELAS.
- Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy.
- Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G
- Aplicação de PCR em tempo real na identificação das mutações A3243G, A8344G e T8993G no mtDNA